Biomarkers of Glioblastoma Progression and Survival
Author Information
Author(s): Serão Nicola VL, Delfino Kristin R, Southey Bruce R, Beever Jonathan E, Rodriguez-Zas Sandra L
Primary Institution: University of Illinois at Urbana-Champaign
Hypothesis
The study aims to identify general and clinical-dependent biomarker genes and biological processes related to glioblastoma survival.
Conclusion
The study confirmed known biomarkers of glioblastoma survival and uncovered new gene profiles that can lead to personalized prognostic tools and therapies.
Supporting Evidence
- 61 gene expression profiles were significantly associated with lifetime survival.
- The majority of identified genes have been previously reported to be associated with glioblastoma.
- New general and clinical-dependent gene profiles were uncovered.
Takeaway
Researchers found important genes that can help predict how long people with glioblastoma might live, which can help doctors give better treatments.
Methodology
The study used a novel analytical strategy involving gene network inference, cross-validation, and functional analyses to identify biomarkers.
Potential Biases
Potential biases may arise from the cohort-dependent associations and the retrospective nature of the data collection.
Limitations
The study's findings may not be generalizable due to the specific cohort characteristics and the limited sample size for certain analyses.
Participant Demographics
The study included 320 individuals diagnosed with glioblastoma, with clinical factors such as gender, race, and therapy considered.
Statistical Information
P-Value
<0.0001
Confidence Interval
0.10-0.32
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website